Souza Gabriela Corrêa, Costa César, Scalco Rosana, Gonçalves Luiz Felipe, Manfro Roberto Ceratti
Division of Nephrology, Hospital de Clínicas de Porto Alegre, Rio Grande do Sul, Brazil.
J Ren Nutr. 2008 Nov;18(6):479-88. doi: 10.1053/j.jrn.2008.05.008.
Our objective was to evaluate serum levels of leptin, body mass index (BMI), body-fat percentage (BF%), and insulin resistance in the first year after renal transplantation.
This study involved a prospective, observational cohort.
The setting was a transplant unit of a university teaching hospital in Porto Alegre, Brazil.
Thirty-two patients who underwent renal transplantation were prospectively followed for 1 year. A control group of 19 healthy individuals, matched by sex, age, and BMI, was included in the study.
Body mass index and BF% were measured according to anthropometric measures, serum leptin was measured by radioimmunoassay, and the homeostasis model assessment (HOMA) was used as an index of insulin resistance. Anthropometric measures and biochemical markers were evaluated prospectively, starting at transplant time and then every 3 months for up to 1 year.
Leptin levels were increased before transplantation, and decreased significantly in the first year (median, 11.9 [interquartile range, 9.2 to 25.2] to 9.3 [4.9 to 16.4] ng/mL; P < .001). The HOMA values presented a similar pattern, decreasing from 2.4 +/- 1.5 (mean +/- SD) before transplantation, to 1.5 +/- 1.1 (P = .001) at 3 months after transplantation, but increasing to 2.0 +/- 1.7 at month 12 after transplantation (P = not significant). The BMI and BF% increased significantly in the first year after transplantation (23.3 +/- 2.7 kg/m(2) vs. 24.4 +/- 2.7 kg/m(2), P = .001, and 23.71% +/- 7.79% vs. 25.63% +/- 7.68%, P = .002, respectively). According to multivariate regression analysis, HOMA levels and BF% independently predicted leptin levels after transplantation.
We found that leptin serum levels decreased significantly over the first posttransplant year. However, the effect of transplantation on insulin resistance appears to be transitory, and BF% also increases steadily in this period. The beneficial profile of leptin levels is counterbalanced by the detrimental effects of insulin resistance and BF% that may be related to the elevated cardiovascular risk observed after transplantation.
我们的目的是评估肾移植后第一年血清瘦素水平、体重指数(BMI)、体脂百分比(BF%)和胰岛素抵抗情况。
本研究为前瞻性观察队列研究。
研究地点为巴西阿雷格里港一所大学教学医院的移植科。
32例接受肾移植的患者被前瞻性随访1年。研究纳入了19名健康个体作为对照组,其在性别、年龄和BMI方面进行了匹配。
根据人体测量学方法测量BMI和BF%,采用放射免疫分析法测量血清瘦素,并使用稳态模型评估(HOMA)作为胰岛素抵抗指标。从移植时开始前瞻性评估人体测量指标和生化标志物,之后每3个月评估一次,共持续1年。
移植前瘦素水平升高,在第一年显著下降(中位数,从11.9[四分位间距,9.2至25.2]降至9.3[4.9至16.4]ng/mL;P<.001)。HOMA值呈现类似模式,从移植前的2.4±1.5(均值±标准差)降至移植后3个月时的1.5±1.1(P=.001),但在移植后12个月时升至2.0±1.7(P=无显著性差异)。移植后第一年BMI和BF%显著增加(分别为23.3±2.7kg/m²对24.4±2.7kg/m²,P=.001;以及23.71%±7.79%对25.63%±7.68%,P=.002)。根据多变量回归分析,HOMA水平和BF%独立预测移植后的瘦素水平。
我们发现移植后第一年血清瘦素水平显著下降。然而,移植对胰岛素抵抗的影响似乎是短暂的,且在此期间BF%也稳步增加。瘦素水平的有益特征被胰岛素抵抗和BF%的有害影响所抵消,这些有害影响可能与移植后观察到的心血管风险升高有关。